Hematology - European Medical Journal

Continue

Hematology

Filter
3 Mins
12 Dec 2019

Anticipate Your Next Move in Chronic Myeloid Leukaemia Patient Management

Treatment decisions in chronic myeloid leukaemia (CML) are complex and require the evaluation of many factors at each stage of therapy…
8 Mins
12 Sep 2019

Variability of Biologics and its Impact on Biosimilar Development

Biologic drugs are transforming treatment of other hard-to-treat diseases beyond cancer, including multiple sclerosis, heart disease, asthma, and…
8 Mins
1 Aug 2019

Rebooting the Myeloma Treatment Programme

Treatment of MM requires a multifaceted approach using a combination of therapies targeting the several pathophysiological pathways involved in the…
3 Mins
1 Aug 2019

Umbilical Cord Blood Donation: An Evolving Lifeline for the Stem Cell Field

Cord blood can be collected and stored from the placenta and umbilical cord following the birth of a new-born. It is replete with haematopoietic stem…
5 Mins
1 Aug 2019

Editor’s Pick: New Insights in β-Thalassaemia

Thalassaemia is a hereditary cause of hypochromic microcytic anaemia resulting from defects in haemoglobin (Hb) production…
6 Mins
1 Aug 2019

Retrospective Review of the Role of Abdominal Imaging in Evaluation of Cytopenias

Specifically, this study examines the use of abdominal imaging, via an ultrasound or CT scan, to identify the aetiology of haematologic abnormalities…
9 Mins
1 Aug 2019

Eltrombopag-Induced Myelofibrosis in Patients with Adult Immune Thrombocytopenia: Scoping Review

Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder that lessens the production of platelets. Despite treatments being available for ITP…
5 Mins
1 Aug 2019

Resistant Bilateral Chylous Effusion as a Late Adverse Effect of Dasatinib Treatment in Chronic Myeloid Leukaemia

Dasatinib is a potent and efficacious second-generation oral tyrosine kinase inhibitor, frequently used for imatinib-resistant or intolerant BCR-ABL+…